Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer.

Journal of Ovarian Research
Qinghong HuLiping HAN

Abstract

We sought to determine the impact of pretreatment plasma platelet levels, dimerized plasmin fragment (D-dimer) and fibrinogen in recurrent epithelial ovarian cancer (EOC) and the impact of platelet levels on SKOV3 cell lines growth and responsiveness to chemotherapy. Under approval of ethical committee, we identified 104 women with recurrent EOC who underwent treatment between January 2010 and February 2015. Reviewing clinical, laboratory, and pathologic records from this retrospective cohort, we analyzed the correlation between pretreatment plasma D-dimer, fibrinogen, platelet levels and clinicopathological parameters, progression free survival (PFS) and overall survival (OS). Inco-culture experiments human ovarian cancer SKOV3 cell lines were used to test the effect of platelet levels on tumor growth and responsiveness to docetaxel. Of the 104 recurrent EOC, thrombocytosis at diagnosis and the decrease of platelet count by less than 25% after primary therapy were associated with worse median progression free survival (P = 0.003;P = 0.021) and median overall survival (P = 0.009;P = 0.009). Mean platelet levels declined at the end of primary therapy(P < 0.001) and rose at recurrence(P = 0.007). In multivariate analysis, elevate...Continue Reading

References

Mar 1, 1992·Asia-Oceania Journal of Obstetrics and Gynaecology·H NishimuraM Yakushiji
Mar 1, 1997·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M den OudenJ W van Wersch
Jan 16, 1999·Gynecologic Oncology·O LavieJ M Monaghan
Oct 20, 2004·British Journal of Pharmacology·Paul JuraszMarek W Radomski
Nov 28, 2008·Blood·Giannoula Lakka KlementJudah Folkman
Jul 9, 2009·Cancer Research·Benoit Ho-Tin-NoéDenisa D Wagner
Sep 5, 2009·The American Journal of Pathology·Benoit Ho-Tin-NoéDenisa D Wagner
Jan 25, 2011·Nature Reviews. Cancer·Laurie J Gay, Brunhilde Felding-Habermann
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Elie A AklHolger Schünemann
Jul 7, 2011·Current Opinion in Urology·Georgios GakisArnulf Stenzl
Feb 18, 2012·The New England Journal of Medicine·Rebecca L StoneAnil K Sood
Mar 10, 2012·Angiogenesis·Jon E PetersonJudah Folkman
Apr 5, 2012·Nature Reviews. Clinical Oncology·Michael J ThunCarlo Patrono
Aug 25, 2012·Gastroenterology·Andrew T Chan
Sep 12, 2012·Blood·Min Soon ChoVahid Afshar-Kharghan
Jan 1, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Min YuTing Niu
Jun 12, 2013·Gynecologic Oncology·S K AllensworthJ N Bakkum-Gamez
Oct 10, 2013·The Journal of Obstetrics and Gynaecology Research·Xuegong MaFengxia Xue
Jun 20, 2014·Clinical & Experimental Metastasis·Karl EganDermot Kenny
Jul 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Myriam LabelleRichard O Hynes
Jan 18, 2013·New Journal of Physics·Michael J Mitchell, Michael R King
Oct 28, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Ya-Nan ManXiong-Zhi Wu
Dec 5, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Justin Bottsford-MillerAnil K Sood
Mar 5, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Ying ChenXiang-Yu Liu
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Nov 5, 2020·International Journal of Molecular Sciences·Demetra H HufnagelAlicia Beeghly-Fadiel

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis